Blood test showdown: which marker best spots cancer comeback?
NCT ID NCT02556281
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 216 people with stage II or III colorectal cancer who had surgery to remove their tumor. Researchers compared two blood tests—one that looks for tumor DNA and another that looks for tumor cells—to see which better predicts if the cancer will come back within two years. No new treatment was given; the goal was simply to learn which test is more accurate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER STAGE II-III are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rouen University Hospital
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can delivering cancer drug directly to the liver shrink tumors?
- Peer power: could community education boost cancer screening?
- AI eye for colonoscopy: could software catch what doctors miss?
- One drop, many cancers? a rapid test aims to spot cancer signals in blood, urine, or saliva
- Could a smartphone photo of stool help detect colon cancer?
- Liver tumors targeted directly: old pump, new drug